Handa Pharmaceuticals, Inc.

TPEX:6620 Voorraadrapport

Marktkapitalisatie: NT$8.6b

Handa Pharmaceuticals Beheer

Beheer criteriumcontroles 1/4

Momenteel beschikken wij niet over voldoende informatie over de CEO.

Belangrijke informatie

Toshiyo Chen

Algemeen directeur

n/a

Totale compensatie

Percentage CEO-salarisn/a
Dienstverband CEOno data
Eigendom CEO0.3%
Management gemiddelde ambtstermijn8.3yrs
Gemiddelde ambtstermijn bestuurgeen gegevens

Recente managementupdates

Recent updates

Handa Pharmaceuticals'(GTSM:6620) Share Price Is Down 26% Over The Past Three Years.

Feb 24
Handa Pharmaceuticals'(GTSM:6620) Share Price Is Down 26% Over The Past Three Years.

We Think Handa Pharmaceuticals (GTSM:6620) Can Afford To Drive Business Growth

Dec 29
We Think Handa Pharmaceuticals (GTSM:6620) Can Afford To Drive Business Growth

CEO

Toshiyo Chen

no data

Tenure

Mr. Toshiyo Chen serves as General Manager and Director of Handa Pharmaceuticals, Inc. Mr. Chen has corporate management experience, specializes in the management, corporate governance, negotiation, market...

Leiderschapsteam

NaamPositieTenureCompensatieEigendom
Fang-Yu Liu
Founder & Chairmanno datageen gegevens0.17%
NT$ 15.0m
Toshiyo Chen
GM & Directorno datageen gegevens0.25%
NT$ 21.5m
Chi-Yu Yang
Vice President of Financeno datageen gegevensgeen gegevens
Guo-Chun Song
Chief Technology Officerno datageen gegevens0.17%
NT$ 14.4m
Zhong-Yi Duan
Vice President of Regulation8.2yrsgeen gegevens0.096%
NT$ 8.3m
Mei-Fang Chang
Senior VP of Quality Affairs & Director8.3yrsgeen gegevens0.34%
NT$ 28.8m
Stephen Cary
Senior Vice President of Business Development8.3yrsgeen gegevens0.035%
NT$ 3.0m

8.3yrs

Gemiddelde duur

Ervaren management: Het managementteam van 6620 is doorgewinterd en ervaren (gemiddelde ambtstermijn van 8.3 jaar).